药物对比
Linagliptin vs Saxagliptin
比较两种DPP-4抑制剂 linagliptin（Tradjenta）与 saxagliptin（Onglyza）治疗2型糖尿病：肾功能调整剂量、心力衰竭风险、疗效和副作用。
此页面暂无可用的对比维度。
临床背景
Triggered when choosing a DPP-4 inhibitor for type 2 diabetes patients with CKD or cardiovascular risk.
结论
Linagliptin is often preferred in renal impairment; saxagliptin requires caution in heart-failure patients; both offer similar A1C lowering.
全部药物对比